Literature DB >> 24995418

The new drug phenomenon.

Simon D Brandt1, Leslie A King, Michael Evans-Brown.   

Abstract

Keywords:  Challenges; Internet; New psychoactive substances

Mesh：

Substances：

Year:  2014        PMID： 24995418     DOI： 10.1002/dta.1686

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN： 1942-7603            Impact factor:   3.345


× No keyword cloud information.
  26 in total

1.  Abuse of New Psychoactive Substances: Threats and Solutions.

Authors:  Michael H Baumann; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2015-08-25       Impact factor: 7.853

2.  Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).

Authors:  Gavin McLaughlin; Noreen Morris; Pierce V Kavanagh; John D Power; Brendan Twamley; John O'Brien; Brian Talbot; Geraldine Dowling; Olivia Mahony; Simon D Brandt; Julian Patrick; Roland P Archer; John S Partilla; Michael H Baumann
Journal:  Drug Test Anal       Date:  2014-10-20       Impact factor: 3.345

Review 3.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

4.  Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.

Authors:  Michael H Baumann; Susruta Majumdar; Valerie Le Rouzic; Amanda Hunkele; Rajendra Uprety; Xi Ping Huang; Jin Xu; Bryan L Roth; Ying-Xian Pan; Gavril W Pasternak
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

Review 5.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

6.  Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-05-10       Impact factor: 3.345

7.  Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.

Authors:  Simon D Brandt; Pierce V Kavanagh; Geraldine Dowling; Brian Talbot; Folker Westphal; Markus R Meyer; Hans H Maurer; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2016-04-21       Impact factor: 3.345

8.  The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.

Authors:  Simon D Brandt; Hailey M Walters; John S Partilla; Bruce E Blough; Pierce V Kavanagh; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2020-09-01       Impact factor: 4.530

9.  Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).

Authors:  Simon D Brandt; Pierce V Kavanagh; Brendan Twamley; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; Landon M Klein; John D McCorvy; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-07-27       Impact factor: 3.345

10.  Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Tristan Colestock; Timothy E Burrow; Stephen J Chapman; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2016-06-06       Impact factor: 3.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.